Cambridge, MA, United States of America
Transkaryotic Therapies, Inc.
Patents = 40
Trademarks = 2
Forward Citations = 1,230
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
15 inventors (with patents filed for the assignee):
Transkaryotic Therapies, Inc. is a biotechnology company focused on developing and commercializing innovative treatments for genetic diseases. With a commitment to transforming the lives of patients, they employ advanced gene therapy and gene editing technologies to address unmet medical needs. Their research and development efforts aim to provide safe and effective therapies for a range of genetic disorders. Visit their website for more information about their groundbreaking work.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com